Loading portfolio…
Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | Equillium, Inc. | $2.61B | 1824977 | 15.94% |
| 2 | Ovid Therapeutics, Inc. | $2.32B | 1781996 | 14.15% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | $1.24B | 1475121 | 7.59% |
| 4 | Shattuck Labs, Inc. | $1.23B | 515619 | 7.53% |
| 5 | Lyell Immunopharma, Inc. | $891.4M | 54887 | 5.45% |
| 6 | American Well Corporation | $478.1M | 77733 | 2.92% |
| 7 | Rani Therapeutics Holdings, Inc. | $101.6M | 203190 | 0.62% |
| 8 | Standard Biotools, Inc. | $21.5M | 16515 | 0.13% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.